Article ID Journal Published Year Pages File Type
5953820 Chest 2015 7 Pages PDF
Abstract
In cross-sectional studies, Aa-Val360 reflects disease severity in AATD and may be a useful marker of disease activity in patients with early disease in whom therapeutic intervention may be indicated.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
The Relationship of the Fibrinogen Cleavage Biomarker Aa-Val360 With Disease Severity and Activity in α1-Antitrypsin Deficiency
Authors
, , , , ,